Severe Bone Marrow Aplasia Following Macrophage Activation Syndrome in Systemic Lupus Erythematosus.
aplastic anemia
hemophagocytic lymphohistiocytosis
macrophage activation syndrome
severe bone marrow aplasia
systemic lupus erythematosus
Journal
The Tohoku journal of experimental medicine
ISSN: 1349-3329
Titre abrégé: Tohoku J Exp Med
Pays: Japan
ID NLM: 0417355
Informations de publication
Date de publication:
11 Aug 2023
11 Aug 2023
Historique:
pubmed:
11
5
2023
medline:
11
5
2023
entrez:
10
5
2023
Statut:
ppublish
Résumé
Macrophage activation syndrome (MAS) is a potentially fatal complication of rheumatic diseases, characterized by activated macrophages with hemophagocytosis and multiple organ damage. We report a case of MAS associated with systemic lupus erythematosus that initially presented with severe liver dysfunction. Although it was improved with steroids and plasmapheresis, severe pancytopenia was subsequently experienced, and the bone marrow showed severe aplasia similar to aplastic anemia. Nevertheless, the administration of immunosuppressants resulted in the recovery of blood counts within two weeks. When severe MAS results in cytokine overproduction, bone marrow aplasia may occur, for which immunosuppressive therapy may be highly effective.
Identifiants
pubmed: 37164698
doi: 10.1620/tjem.2023.J037
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM